A leader from the company advises planning ahead when filing investigational new drug applications to avoid wasting time, work and money later.
Markets & Regulations
The federal government continues to offer life-sciences professionals advice and resources as they pursue treatments to help fight the COVID-19 virus.
Under the terms of the contract, Gilead will supply the EC with up to half a million treatment courses of Veklury to treat COVID-19 patients.
Technology impacting generic drugs include artificial intelligence, telemedicine, fraud-preventing digital solutions and more, according to a report
The popular pharma industry conferences plan to combine live and digital elements when assembling its calendar of international events next year.
As the pandemic maintains its hold, the US agency continues to issue advice and take action related to testing, treatment and information on the virus.
The survey, unveiled ahead of next week’s CPhI Festival of Pharma, reveals perspectives, concerns and future plans of more than 500 industry executives.
The agency continues to take actions and issue advice related to COVID-19 treatments, tests, consumer products and other pressing industry concerns.
The pharmaceutical technology investment fund is partnering with and financing Atomwise, a company that provides AI solutions for drug discovery
The US federal agency continues to keep busy offering resources, issuing EUAs and taking action related to the COVID-19 pandemic.
The agency continues to provide resources for the life-sciences industry, approve tests, and take action against companies offering false treatments
The bipartisan bill calls for an assessment of the countryâs pharma supply chain, including potential vulnerabilities and impact of foreign manufacturing.
The US agency continues to put out informational resources, issue EUAs for tests and treatments, and monitor industry activity related to the virus.
The US agency continues releasing resources, offering advice and taking actions related to the pandemic, and how life-sciences professionals respond.
As the virus behind the pandemic continues to impact the globe, the federal agency continues to offer advice and take action in response to the virus.
The agency continues to offer advice to pharma industry professionals during the global public health crisis, and offer advice on developing solutions.